At the DNA level, the genetic polymorphism A-202C of IGFBP3 (SNP, rs2854744) at the promoter region has been extensively studied for potential associations with circulating IGFBP3 levels and BrCa risk. Here, IGFBP3 is linked to invasive breast carcinoma.